Vibeke Strand, MD, evaluates implementation of biosimilars in patients with no history of reference biologic use.
This is a video synopsis/summary of a panel discussion involving a multidisciplinary team of experts: Ryan Haumschild, PharmD, MS, MBA; Alice B. Gottlieb, MD, PhD; Bincy Abraham, MD, MS; Jamie T. Brogan, APRN; and Vibeke Strand, MD. In this segment, the focus shifts to the initiation of biosimilars, particularly for patients who have never been prescribed the originator biologic.
Haumschild begins the conversation by underscoring the significance of the patient perspective in initiating biosimilars. He emphasizes the role of shared decision-making in this context, acknowledging that discussions might differ when initiating someone who has never received the reference biologic compared with someone who has experience with it.
Strand, an authoritative voice in rheumatology, offers insights into best practices for initiating biosimilars in patients unfamiliar with the reference biologic. She emphasizes the importance of shared decision-making and anticipates scenarios where providers may need to make informed decisions on behalf of patients. Strand highlights the critical role of explaining biosimilars comprehensively to mitigate the nocebo effect, emphasizing the need for patient education.
Video synopsis is AI-generated and reviewed by AJMC editorial staff.
Provisional CDC data show that US babies gained roughly a year in life expectancy in 2022; study findings indicate that the COVID-19 pandemic significantly raised the risk of preterm birth for expectant California mothers; New York Attorney General Letitia James said about 4 million New Yorkers were affected by a data breach of the medical transcription company Perry Johnson & Associates.
Read More
Understanding the Unmet Need for Therapies to Treat Rare Bile Duct Cancer
May 24th 2022On this episode of Managed Care Cast, we bring you an excerpt of an interview with a co-chair of the 2022 Cholangiocarcinoma Foundation (CCF) annual conference, held earlier this year, about the significant unmet therapy needs facing most patients with this rare cancer.
Listen
A Look at Racial Disparities in US HPV Vaccine Uptake
March 1st 2022On this episode of Managed Care Cast, Leslie Cofie, PhD, MPH, an assistant professor of health education and promotion at the College of Health and Human Performance, East Carolina University, discusses his work on identifying and addressing racial disparities in human papillomavirus (HPV) vaccine uptake in the United States.
Listen